FDA issued a Warning Letter to LifeCell Corporation on 5/5/2011 for a previous inspection.
483 LifeCell, A Wholly Owned Subsidiary of Allergan Aug 2017

483 LifeCell, A Wholly Owned Subsidiary of Allergan Aug 2017

$119 - Not in Stock

FDA investigators audited the LifeCell, A Wholly Owned Subsidiary of Allergan - Branchburg, NJ, United States facility and issued inspectional observations (via FDA 483) on 25 Aug 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 25 Aug 2017
  • Location: Branchburg, United States
  • FEI: 1000306051
Order